peripheral-vascular
(2)
The Clot Has to Come Out Whole
Vesalio began with a neurosurgeon’s complaint about stubborn clots. Now its pocketed retrievers work across brain, heart and limb - and a randomized coronary trial gives the company a new question to answer.
Howard Rosen
Howard Rosen is the CEO and co-founder of Evident Vascular, a San Jose medtech startup building an AI-powered intravascular ultrasound (IVUS) platform for peripheral and coronary interventions. A 30-year cardiovascular device veteran, he spent 21 years at Boston Scientific before helping guide Intact Vascular and its spinout Vesper Medical through acquisitions by Philips. He launched Evident out of stealth in 2023 with a $35 million Series A led by Vensana Capital and closed a Series B in 2025. He is known for a disciplined 'go slow to go fast' company-building philosophy.